This company has shut down. GDMC is no longer operating — its last tracked round was a Series A in 2024.
Explore the Startup GraveyardGDMC is a pharmaceutical company that engages in manufacturing and designing genetic medicines.
GDMC has raised $21.0M in total funding. The most recent round was Series A. The last funding was announced in January 2024.
GDMC's investors include WI Harper Group, Celadon Partners, Seeds Capital, NSG Ventures.
GDMC is headquartered in Bukit Merah, Singapore.
GDMC is a pharmaceutical company that engages in manufacturing and designing genetic medicines.
GDMC is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"GDMC — Funding & Investors." VCBacked, January 24, 2024, https://www.vcbacked.co/company/gdmc. Accessed September 30, 2026.
VCBacked. (2024). GDMC — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/gdmc
{{cite web |title=GDMC — Funding & Investors |url=https://www.vcbacked.co/company/gdmc |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated